More
    Guided Solutions - Connecting Talent With Innovation/div>

    ViCentra adds $13M in second close of Series D funding round

    ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing commercialisation efforts for its...

    BrightHeart raises €11M Series A to scale AI platform for prenatal ultrasound

    BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, announced the closing of an €11 million Series A financing round. The...

    FineHeart secures additional €35M to support its growth

    FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced the completion of a €35 million first closing...

    Spiro Medical raises $67M Series A to support neuromod tech

    Spiro Medical announced that it closed a $67 million Series A equity financing to support its neuromodulation system. Irvine, California-based Spiro develops a first-of-its-kind pulmonary...

    Surgerii Robotics raises $100M to take single-port surgical robotics system global

    Surgerii Robotics has closed $100 million in Series D financing. The Beijing-based company said last month that it will use the funding to market its...

    Biobeat secures $50M Series B financing

    Biobeat Technologies, developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment...

    Ultromics secures strategic investment from the American Heart Association

    Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association’s Go Red for Women Venture Fund, a fund...

    Olympus launches second VC fund with $150m commitment

    Olympus Corporation has committed $150m to a new venture capital (VC) fund, aiming to deploy the capital to promising medtech startups in the gastrointestinal...

    Subsense expands financing to $27M for non-surgical brain-computer interfaces

    Subsense, a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding...

    Latest articles